Aerie Pharma (AERI) Lower with Feuerstein Out Negative

September 21, 2016 9:31 AM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Recent momentum stock Aerie Pharma (NASDAQ: AERI) is down 5% in pre-open trade after TheStreet's Adam Feuerstein made cautious comments on the stock.

According to Feuerstein, the company produced positive clinical trial results after enrolling patients with only borderline glaucoma.


Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

FDA, Momentum Movers, Trader Talk

Related Entities

Pre Market Movers, Adam Feuerstein

Add Your Comment